| Consumer Staples Distribution & Retail Industry | Consumer Staples Sector | - CEO | KRX SM Exchange | - ISIN |
| South Korea Country | 12 Employees | - Last Dividend | 26 Feb 2025 Last Split | - IPO Date |
BL Pharmtech Corp., originally known as Next BT Co., Ltd., stands as a multifaceted entity primarily engaged in the manufacturing, retailing, importation, and exportation of health functional foods within South Korea. The foundation of its operations, established in 1995, is strongly rooted in the heart of Yongin, South Korea. Over the years, BL Pharmtech has expanded its horizons beyond its initial focus, venturing into the biotechnology sector and the cosmetic manufacturing industry. This diversification reflects the company's commitment to innovation and its ability to adapt to the evolving demands of both the health and beauty markets. BL Pharmtech Corp. prides itself on its deep-seated knowledge and substantial experience in biotechnology, which serves as a backbone for its product development and business operations.
As of my last knowledge update, specific details about BL Pharmtech Corp.'s current products and services are not readily available, thus making it challenging to provide an updated listing or description of the offerings directly from their official website or other direct sources. Traditionally, companies involved in the sectors mentioned (health functional foods, biotechnology, and cosmetics manufacturing) offer a broad range of products and services, including but not limited to:
This general overview is reflective of common offerings within these sectors; however, the specific portfolio of BL Pharmtech Corp. may include unique proprietary products and services distinct to their brand and expertise.